Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.85 SEK | -1.91% | -3.85% | -53.87% |
Mar. 01 | Sana Biotechnology Shares Rise as Q4 Non-GAAP Net Loss Narrows | MT |
Mar. 01 | Sector Update: Health Care Stocks Edge Higher Premarket Friday | MT |
Sales 2023 | 16.84M 1.54M | Sales 2024 * | 62M 5.68M | Capitalization | 206M 18.85M |
---|---|---|---|---|---|
Net income 2023 | -95M -8.7M | Net income 2024 * | -37M -3.39M | EV / Sales 2023 | 15.3 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 3.32 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 23 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 69.76% |
1 day | -1.91% | ||
1 week | -3.85% | ||
Current month | -4.05% | ||
1 month | +0.54% | ||
3 months | -24.18% | ||
6 months | -66.24% | ||
Current year | -53.87% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 66 | 10-12-31 | |
Thomas Feldthus
CEO | Chief Executive Officer | 64 | 10-12-31 |
Jørgen Drejer
FOU | Founder | 69 | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jørgen Drejer
FOU | Founder | 69 | 10-12-31 |
Director/Board Member | 66 | 14-12-31 | |
Anna Ljung
BRD | Director/Board Member | 44 | 18-01-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 1.85 | -1.91% | 320,759 |
24-04-18 | 1.886 | +3.29% | 179,686 |
24-04-17 | 1.826 | +0.33% | 82,439 |
24-04-16 | 1.82 | -2.15% | 95,520 |
24-04-15 | 1.86 | -3.33% | 231,004 |
Delayed Quote Nasdaq Stockholm, April 19, 2024 at 11:29 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-53.87% | 19.2M | |
-3.10% | 102B | |
+2.11% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.19% | 13.79B | |
+0.18% | 13.33B | |
+19.90% | 10.94B |
- Stock Market
- Equities
- SANION Stock